Bispecific antibody against human c-met and human EGFR, and use thereof
WO2025247296A1PCT designated stage Publication Date: 2025-12-04IMBIORAY (HANGZHOU) BIOMEDICINE CO LTD
Patent Information
- Application Number
- PCT/CN2025/097888
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-05-30
- Filing Date
- 2025-05-29
- Publication Date
- 2025-12-04
Smart Images
Figure CN2025097888_04122025_PF_FP_ABST
Abstract
Provided in the present application is a bispecific antibody, which contains a first antigen-binding fragment against a human mesenchymal-epithelial transition factor (c-Met) and a second antigen-binding fragment against a human epidermal growth factor receptor (EGFR). In addition, further provided in the present application is the medical and biological use of the bispecific antibody.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Bispecific EGFR / c-Met antibodies
CN104955838A
Antibodies binded with EGFR and cMET
CN111094351A
Stable formulations comprising bispecific EGFR / C-MET antibodies
CN116194485A
High concentration bispecific antibody formulations
CN117177740A